Japanese firm invests $11.4 mn in TB and malaria research

Singapore: With a view to curb the menace of malaria and tuberculosis(TB), Japan's investment firm, Global Health Innova...

November 3, 2016 | Thursday | News
Cardinal Health expands cardiovascular portfolio

Singapore: Cardinal Health has expanded its current distribution agreement with Biosensors as the exclusive distributor...

November 2, 2016 | Wednesday | News
Clinigen makes foray into Japan

Singapore: Further building on its presence in the Asian region, Burton-based Clinigen Group,has launched its Japanese b...

October 19, 2016 | Wednesday | News
Japan's Towa Phamaceuticals to enter the US market

Singapore: Japanese drug giant Towa Pharmaceuticals makes foray into the US markets banking on its new set of pills that...

November 15, 2016 | Tuesday | News
India urges Japan to provide wider pharma market access

Singapore: The Indian commerce Minister, Ms Nirmala Sitharaman has urged Japan to provide Indian pharmaceutical sector w...

October 14, 2016 | Friday | News
Zydus Cadila, Takeda to co-develop vaccine for chikungunya

Singapore: Japan's Takeda pharmaceuticals has joined hands with India-based Zydus Cadila in an aim to co-develop a vacci...

September 23, 2016 | Friday | News
Japan market forecast

Singapore: Japan's demographic profile will continue to create revenue earning opportunities for the pharmaceuticals and...

January 20, 2016 | Wednesday | Opinion
Stem cell scientist sues Nobel laureate for deception

Singapore: Dr Rongxiang Xu, a scientist who claims to be the founder of human body regenerative restoration science, has...

May 17, 2013 | Friday | News
Niigata Univ stroke therapy license for Shimojani

Singapore: Shimojani obtained exclusive license from Japan's Niigata University for worldwide development and commercia...

February 25, 2013 | Monday | News
Astellas prostrate cancer drug gets EU nod

Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic ...

June 25, 2013 | Tuesday | News
Columbia Asia receives $101mn investment from Mitsui & Co.

Singapore: Columbia Asia has announced it is receiving $101 million in investment from Mitsui & Co., Ltd. Columbia ...

July 27, 2016 | Wednesday | News
Teijin, Versartis partner for commercialization of Somavaratan in Japan

Singapore: Teijin Limited and Versartis, Inc. has announced that the companies and their wholly owned subsidiaries have ...

August 11, 2016 | Thursday | News
Tivozanib shows superiority over sorafenib in trial

Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS su...

May 18, 2012 | Friday | News
Chugai gets positive outcome from Actemra Subcutaneous Injection trials

Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemr...

May 17, 2016 | Tuesday | News
Prosetta Biosciences, Takeda to co-discover drugs for neurodegenerative diseases

Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Ph...

May 3, 2016 | Tuesday | News
Histogenics to develop Purpose's NeoCart for Japanese Market

Histogenics Corporation, a NASDAQ-listed regenerative medicine company focused on developing and commercializing product...

May 11, 2016 | Wednesday | News
NCRM gets Japanese patent for nanotechnology-based corneal stem cell transplant

Tokyo: Corneal endothelial precursor cell transplantation methodology, employing a Nanocomposite gel sheet has been awar...

February 1, 2016 | Monday | News
Allergan's Botox Vista receives marketing authorization in Japan

Dublin-headquartered Allergan plc has announced that the Japanese Ministry of Health, Labour and Welfare has approved an...

May 25, 2016 | Wednesday | News